News
Wolfe Research Initiates Coverage On Madrigal Pharmaceuticals with Outperform Rating
11 Jun 24
News, Initiation, Analyst Ratings
10 Health Care Stocks With Whale Alerts In Today's Session
11 Jun 24
Options
Madrigal Pharmaceuticals Announces New Analyses From Phase 3 MAESTRO-NASH Trial Of Resmetirom To Be Presented At EASL Congress, June 5-8, 2024 In Milan, Italy
6 Jun 24
Biotech, News, General
What's Going On With Fattly Liver Disease Focused Madrigal Pharmaceuticals, Sagimet Biosciences Shares On Wednesday?
5 Jun 24
Biotech, Large Cap, News, Health Care, Top Stories, Movers, Media, General
DouYu International Posts Q1 Results, Joins Annexon, Dollar Tree And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
5 Jun 24
News, Pre-Market Outlook, Markets, Movers, Trading Ideas
B. Riley Securities Maintains Neutral on Madrigal Pharmaceuticals, Lowers Price Target to $200
10 May 24
News, Price Target, Analyst Ratings
HC Wainwright & Co. Maintains Buy on Madrigal Pharmaceuticals, Lowers Price Target to $390
8 May 24
News, Price Target, Analyst Ratings
Citigroup Maintains Buy on Madrigal Pharmaceuticals, Lowers Price Target to $382
8 May 24
News, Price Target, Analyst Ratings
JMP Securities Maintains Market Outperform on Madrigal Pharmaceuticals, Lowers Price Target to $381
8 May 24
News, Price Target, Analyst Ratings
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
7 May 24
Movers
Madrigal Pharmaceuticals Q1 2024 GAAP EPS $(7.38) Misses $(6.17) Estimate
7 May 24
Earnings, Earnings Misses, News
10 Health Care Stocks Whale Activity In Today's Session
3 May 24
Options
Press releases
Madrigal Statement on the Passing of Dr. Stephen Harrison
24 Apr 24
Health Care, Press Releases
Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
16 Apr 24
Press Releases
Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
3 Apr 24
Markets, Press Releases